nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Topoisomerase Inhibitors—Etoposide—brain cancer	0.561	1	CiPCiCtD
Idarubicin—CYP2C9—brain cancer	0.229	1	CbGaD
Idarubicin—TOP2A—Etoposide—brain cancer	0.0572	0.405	CbGbCtD
Idarubicin—ABCC1—Etoposide—brain cancer	0.0317	0.224	CbGbCtD
Idarubicin—CYP2D6—Lomustine—brain cancer	0.0298	0.211	CbGbCtD
Idarubicin—CYP2D6—Hydroxyurea—brain cancer	0.0226	0.16	CbGbCtD
Idarubicin—Gastrointestinal toxicity—Lomustine—brain cancer	0.00401	0.0614	CcSEcCtD
Idarubicin—Radiation injury—Hydroxyurea—brain cancer	0.00309	0.0472	CcSEcCtD
Idarubicin—Radiation injury—Temozolomide—brain cancer	0.00241	0.0369	CcSEcCtD
Idarubicin—Recall phenomenon—Hydroxyurea—brain cancer	0.00187	0.0286	CcSEcCtD
Idarubicin—Cardiotoxicity—Procarbazine—brain cancer	0.00178	0.0272	CcSEcCtD
Idarubicin—Palmar-plantar erythrodysaesthesia syndrome—Etoposide—brain cancer	0.00176	0.0269	CcSEcCtD
Idarubicin—Gastrointestinal toxicity—Carmustine—brain cancer	0.00159	0.0244	CcSEcCtD
Idarubicin—Myelosuppression—Lomustine—brain cancer	0.00141	0.0215	CcSEcCtD
Idarubicin—Myelodysplastic syndrome—Temozolomide—brain cancer	0.00126	0.0193	CcSEcCtD
Idarubicin—Radiation recall reaction (dermatologic)—Etoposide—brain cancer	0.00123	0.0189	CcSEcCtD
Idarubicin—Gastrointestinal toxicity—Etoposide—brain cancer	0.00123	0.0189	CcSEcCtD
Idarubicin—Fluid overload—Carboplatin—brain cancer	0.00121	0.0185	CcSEcCtD
Idarubicin—Leukaemia—Hydroxyurea—brain cancer	0.0012	0.0184	CcSEcCtD
Idarubicin—Recall phenomenon—Etoposide—brain cancer	0.00117	0.0178	CcSEcCtD
Idarubicin—Pericarditis—Procarbazine—brain cancer	0.000967	0.0148	CcSEcCtD
Idarubicin—Septicemia—Etoposide—brain cancer	0.000892	0.0136	CcSEcCtD
Idarubicin—Alopecia reversible—Etoposide—brain cancer	0.000892	0.0136	CcSEcCtD
Idarubicin—Extravasation—Carboplatin—brain cancer	0.000863	0.0132	CcSEcCtD
Idarubicin—Cardiotoxicity—Etoposide—brain cancer	0.000859	0.0131	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Procarbazine—brain cancer	0.000703	0.0108	CcSEcCtD
Idarubicin—Febrile neutropenia—Procarbazine—brain cancer	0.000695	0.0106	CcSEcCtD
Idarubicin—Myelosuppression—Hydroxyurea—brain cancer	0.000691	0.0106	CcSEcCtD
Idarubicin—Septic shock—Etoposide—brain cancer	0.00067	0.0103	CcSEcCtD
Idarubicin—Phlebitis—Carboplatin—brain cancer	0.000635	0.00971	CcSEcCtD
Idarubicin—Neoplasm—Lomustine—brain cancer	0.000596	0.00911	CcSEcCtD
Idarubicin—Mucosal inflammation—Hydroxyurea—brain cancer	0.000585	0.00894	CcSEcCtD
Idarubicin—Myelosuppression—Carmustine—brain cancer	0.000558	0.00854	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Hydroxyurea—brain cancer	0.000544	0.00833	CcSEcCtD
Idarubicin—Myelosuppression—Temozolomide—brain cancer	0.000539	0.00825	CcSEcCtD
Idarubicin—Febrile neutropenia—Hydroxyurea—brain cancer	0.000538	0.00823	CcSEcCtD
Idarubicin—TOP2A—Teniposide—Etoposide—brain cancer	0.000492	0.5	CbGdCrCtD
Idarubicin—TOP2A—Podofilox—Etoposide—brain cancer	0.000492	0.5	CbGdCrCtD
Idarubicin—Bone marrow depression—Hydroxyurea—brain cancer	0.00048	0.00734	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Carmustine—brain cancer	0.00044	0.00673	CcSEcCtD
Idarubicin—Febrile neutropenia—Carmustine—brain cancer	0.000435	0.00665	CcSEcCtD
Idarubicin—Myelosuppression—Etoposide—brain cancer	0.000432	0.0066	CcSEcCtD
Idarubicin—TOP2A—Gastric Cancer Network 2—S100A6—brain cancer	0.000424	0.138	CbGpPWpGaD
Idarubicin—Febrile neutropenia—Temozolomide—brain cancer	0.00042	0.00643	CcSEcCtD
Idarubicin—Embolism—Temozolomide—brain cancer	0.000394	0.00603	CcSEcCtD
Idarubicin—Pancytopenia—Lomustine—brain cancer	0.000393	0.00601	CcSEcCtD
Idarubicin—Burning sensation—Carmustine—brain cancer	0.000377	0.00576	CcSEcCtD
Idarubicin—Mucosal inflammation—Etoposide—brain cancer	0.000366	0.00559	CcSEcCtD
Idarubicin—Stomatitis—Lomustine—brain cancer	0.000359	0.0055	CcSEcCtD
Idarubicin—Hyperuricaemia—Hydroxyurea—brain cancer	0.000349	0.00534	CcSEcCtD
Idarubicin—Hepatic function abnormal—Procarbazine—brain cancer	0.000348	0.00532	CcSEcCtD
Idarubicin—Ulcer—Hydroxyurea—brain cancer	0.000342	0.00524	CcSEcCtD
Idarubicin—Febrile neutropenia—Etoposide—brain cancer	0.000336	0.00515	CcSEcCtD
Idarubicin—Necrosis—Carmustine—brain cancer	0.000333	0.0051	CcSEcCtD
Idarubicin—Haemoglobin—Lomustine—brain cancer	0.000333	0.00509	CcSEcCtD
Idarubicin—Haemorrhage—Lomustine—brain cancer	0.000331	0.00506	CcSEcCtD
Idarubicin—Blood uric acid increased—Hydroxyurea—brain cancer	0.00033	0.00504	CcSEcCtD
Idarubicin—Extravasation—Carmustine—brain cancer	0.0003	0.00459	CcSEcCtD
Idarubicin—Neoplasm—Hydroxyurea—brain cancer	0.000293	0.00448	CcSEcCtD
Idarubicin—Alopecia—Lomustine—brain cancer	0.000292	0.00447	CcSEcCtD
Idarubicin—Infection—Carboplatin—brain cancer	0.000267	0.00408	CcSEcCtD
Idarubicin—Necrosis—Etoposide—brain cancer	0.000258	0.00394	CcSEcCtD
Idarubicin—Leukopenia—Lomustine—brain cancer	0.000258	0.00394	CcSEcCtD
Idarubicin—Pancytopenia—Procarbazine—brain cancer	0.000249	0.00381	CcSEcCtD
Idarubicin—Neoplasm—Carmustine—brain cancer	0.000237	0.00362	CcSEcCtD
Idarubicin—Infection—Lomustine—brain cancer	0.000234	0.00357	CcSEcCtD
Idarubicin—Extravasation—Etoposide—brain cancer	0.000232	0.00355	CcSEcCtD
Idarubicin—Thrombocytopenia—Lomustine—brain cancer	0.00023	0.00352	CcSEcCtD
Idarubicin—Neoplasm—Temozolomide—brain cancer	0.000229	0.0035	CcSEcCtD
Idarubicin—Stomatitis—Procarbazine—brain cancer	0.000228	0.00349	CcSEcCtD
Idarubicin—Sepsis—Carmustine—brain cancer	0.000227	0.00347	CcSEcCtD
Idarubicin—Anorexia—Lomustine—brain cancer	0.000224	0.00343	CcSEcCtD
Idarubicin—Phlebitis—Carmustine—brain cancer	0.000221	0.00337	CcSEcCtD
Idarubicin—Thrombophlebitis—Carmustine—brain cancer	0.000219	0.00336	CcSEcCtD
Idarubicin—Hyperuricaemia—Etoposide—brain cancer	0.000218	0.00334	CcSEcCtD
Idarubicin—Ulcer—Etoposide—brain cancer	0.000214	0.00327	CcSEcCtD
Idarubicin—Body temperature increased—Carboplatin—brain cancer	0.000212	0.00325	CcSEcCtD
Idarubicin—Thrombophlebitis—Temozolomide—brain cancer	0.000212	0.00324	CcSEcCtD
Idarubicin—Haemoglobin—Procarbazine—brain cancer	0.000211	0.00323	CcSEcCtD
Idarubicin—Haemorrhage—Procarbazine—brain cancer	0.00021	0.00321	CcSEcCtD
Idarubicin—Blood uric acid increased—Etoposide—brain cancer	0.000206	0.00315	CcSEcCtD
Idarubicin—Decreased appetite—Lomustine—brain cancer	0.000204	0.00313	CcSEcCtD
Idarubicin—Hot flush—Temozolomide—brain cancer	0.000196	0.003	CcSEcCtD
Idarubicin—Flushing—Procarbazine—brain cancer	0.000195	0.00298	CcSEcCtD
Idarubicin—Menopausal symptoms—Temozolomide—brain cancer	0.000195	0.00298	CcSEcCtD
Idarubicin—Pancytopenia—Hydroxyurea—brain cancer	0.000193	0.00295	CcSEcCtD
Idarubicin—Neutropenia—Hydroxyurea—brain cancer	0.00019	0.00291	CcSEcCtD
Idarubicin—Chills—Procarbazine—brain cancer	0.000189	0.00288	CcSEcCtD
Idarubicin—Arrhythmia—Procarbazine—brain cancer	0.000188	0.00287	CcSEcCtD
Idarubicin—Body temperature increased—Lomustine—brain cancer	0.000186	0.00284	CcSEcCtD
Idarubicin—Alopecia—Procarbazine—brain cancer	0.000186	0.00284	CcSEcCtD
Idarubicin—Oesophagitis—Etoposide—brain cancer	0.000185	0.00283	CcSEcCtD
Idarubicin—Stomatitis—Hydroxyurea—brain cancer	0.000177	0.0027	CcSEcCtD
Idarubicin—Sepsis—Etoposide—brain cancer	0.000176	0.00269	CcSEcCtD
Idarubicin—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000173	0.0562	CbGpPWpGaD
Idarubicin—Dehydration—Temozolomide—brain cancer	0.000171	0.00261	CcSEcCtD
Idarubicin—Phlebitis—Etoposide—brain cancer	0.000171	0.00261	CcSEcCtD
Idarubicin—Anaemia—Procarbazine—brain cancer	0.000169	0.00259	CcSEcCtD
Idarubicin—Leukopenia—Procarbazine—brain cancer	0.000164	0.0025	CcSEcCtD
Idarubicin—Haemoglobin—Hydroxyurea—brain cancer	0.000163	0.0025	CcSEcCtD
Idarubicin—Haemorrhage—Hydroxyurea—brain cancer	0.000163	0.00249	CcSEcCtD
Idarubicin—Cardiac failure congestive—Etoposide—brain cancer	0.000162	0.00248	CcSEcCtD
Idarubicin—Convulsion—Procarbazine—brain cancer	0.000158	0.00242	CcSEcCtD
Idarubicin—Pancytopenia—Carmustine—brain cancer	0.000156	0.00239	CcSEcCtD
Idarubicin—Neutropenia—Carmustine—brain cancer	0.000154	0.00235	CcSEcCtD
Idarubicin—Pancytopenia—Temozolomide—brain cancer	0.000151	0.00231	CcSEcCtD
Idarubicin—Vomiting—Lomustine—brain cancer	0.000149	0.00229	CcSEcCtD
Idarubicin—Neutropenia—Temozolomide—brain cancer	0.000148	0.00227	CcSEcCtD
Idarubicin—Infection—Procarbazine—brain cancer	0.000148	0.00227	CcSEcCtD
Idarubicin—Angiopathy—Hydroxyurea—brain cancer	0.000148	0.00226	CcSEcCtD
Idarubicin—Shock—Procarbazine—brain cancer	0.000147	0.00225	CcSEcCtD
Idarubicin—Thrombocytopenia—Procarbazine—brain cancer	0.000146	0.00224	CcSEcCtD
Idarubicin—Chills—Hydroxyurea—brain cancer	0.000146	0.00223	CcSEcCtD
Idarubicin—Alopecia—Hydroxyurea—brain cancer	0.000144	0.0022	CcSEcCtD
Idarubicin—Stomatitis—Carmustine—brain cancer	0.000143	0.00218	CcSEcCtD
Idarubicin—Anorexia—Procarbazine—brain cancer	0.000142	0.00218	CcSEcCtD
Idarubicin—Nausea—Lomustine—brain cancer	0.00014	0.00214	CcSEcCtD
Idarubicin—Stomatitis—Temozolomide—brain cancer	0.000138	0.00211	CcSEcCtD
Idarubicin—Haemoglobin—Carmustine—brain cancer	0.000132	0.00202	CcSEcCtD
Idarubicin—Haemorrhage—Carmustine—brain cancer	0.000131	0.00201	CcSEcCtD
Idarubicin—Anaemia—Hydroxyurea—brain cancer	0.000131	0.002	CcSEcCtD
Idarubicin—Decreased appetite—Procarbazine—brain cancer	0.00013	0.00198	CcSEcCtD
Idarubicin—Haemoglobin—Temozolomide—brain cancer	0.000128	0.00195	CcSEcCtD
Idarubicin—Haemorrhage—Temozolomide—brain cancer	0.000127	0.00194	CcSEcCtD
Idarubicin—Leukopenia—Hydroxyurea—brain cancer	0.000127	0.00194	CcSEcCtD
Idarubicin—Urinary tract disorder—Temozolomide—brain cancer	0.000125	0.00192	CcSEcCtD
Idarubicin—Urethral disorder—Temozolomide—brain cancer	0.000125	0.0019	CcSEcCtD
Idarubicin—Convulsion—Hydroxyurea—brain cancer	0.000123	0.00188	CcSEcCtD
Idarubicin—Gastrointestinal pain—Procarbazine—brain cancer	0.000122	0.00187	CcSEcCtD
Idarubicin—Flushing—Carmustine—brain cancer	0.000122	0.00187	CcSEcCtD
Idarubicin—Pancytopenia—Etoposide—brain cancer	0.000121	0.00184	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00012	0.00183	CcSEcCtD
Idarubicin—Neutropenia—Etoposide—brain cancer	0.000119	0.00182	CcSEcCtD
Idarubicin—Urticaria—Procarbazine—brain cancer	0.000119	0.00181	CcSEcCtD
Idarubicin—Body temperature increased—Procarbazine—brain cancer	0.000118	0.0018	CcSEcCtD
Idarubicin—Abdominal pain—Procarbazine—brain cancer	0.000118	0.0018	CcSEcCtD
Idarubicin—Flushing—Temozolomide—brain cancer	0.000118	0.0018	CcSEcCtD
Idarubicin—Arrhythmia—Carmustine—brain cancer	0.000117	0.0018	CcSEcCtD
Idarubicin—Alopecia—Carmustine—brain cancer	0.000116	0.00178	CcSEcCtD
Idarubicin—Angiopathy—Temozolomide—brain cancer	0.000115	0.00176	CcSEcCtD
Idarubicin—ABCC1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000115	0.0373	CbGpPWpGaD
Idarubicin—Infection—Hydroxyurea—brain cancer	0.000115	0.00176	CcSEcCtD
Idarubicin—Immune system disorder—Temozolomide—brain cancer	0.000115	0.00175	CcSEcCtD
Idarubicin—Malnutrition—Carmustine—brain cancer	0.000114	0.00175	CcSEcCtD
Idarubicin—Chills—Temozolomide—brain cancer	0.000114	0.00174	CcSEcCtD
Idarubicin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000113	0.00173	CcSEcCtD
Idarubicin—Alopecia—Temozolomide—brain cancer	0.000112	0.00172	CcSEcCtD
Idarubicin—Skin disorder—Hydroxyurea—brain cancer	0.000112	0.00172	CcSEcCtD
Idarubicin—Acute coronary syndrome—Etoposide—brain cancer	0.000112	0.00171	CcSEcCtD
Idarubicin—Myocardial infarction—Etoposide—brain cancer	0.000111	0.0017	CcSEcCtD
Idarubicin—Malnutrition—Temozolomide—brain cancer	0.000111	0.00169	CcSEcCtD
Idarubicin—Stomatitis—Etoposide—brain cancer	0.00011	0.00169	CcSEcCtD
Idarubicin—Anorexia—Hydroxyurea—brain cancer	0.00011	0.00168	CcSEcCtD
Idarubicin—Hypersensitivity—Procarbazine—brain cancer	0.00011	0.00168	CcSEcCtD
Idarubicin—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000107	0.0348	CbGpPWpGaD
Idarubicin—TOP2A—G0 and Early G1—CCNE1—brain cancer	0.000106	0.0345	CbGpPWpGaD
Idarubicin—Anaemia—Carmustine—brain cancer	0.000106	0.00162	CcSEcCtD
Idarubicin—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000103	0.0335	CbGpPWpGaD
Idarubicin—Leukopenia—Carmustine—brain cancer	0.000102	0.00157	CcSEcCtD
Idarubicin—Anaemia—Temozolomide—brain cancer	0.000102	0.00156	CcSEcCtD
Idarubicin—Diarrhoea—Procarbazine—brain cancer	0.000102	0.00156	CcSEcCtD
Idarubicin—Decreased appetite—Hydroxyurea—brain cancer	0.0001	0.00154	CcSEcCtD
Idarubicin—Urinary tract disorder—Etoposide—brain cancer	0.0001	0.00154	CcSEcCtD
Idarubicin—Urethral disorder—Etoposide—brain cancer	9.96e-05	0.00152	CcSEcCtD
Idarubicin—Convulsion—Carmustine—brain cancer	9.91e-05	0.00152	CcSEcCtD
Idarubicin—Leukopenia—Temozolomide—brain cancer	9.9e-05	0.00151	CcSEcCtD
Idarubicin—Chest pain—Carmustine—brain cancer	9.74e-05	0.00149	CcSEcCtD
Idarubicin—Convulsion—Temozolomide—brain cancer	9.58e-05	0.00147	CcSEcCtD
Idarubicin—Vomiting—Procarbazine—brain cancer	9.49e-05	0.00145	CcSEcCtD
Idarubicin—Flushing—Etoposide—brain cancer	9.43e-05	0.00144	CcSEcCtD
Idarubicin—TOP2A—G0 and Early G1—PCNA—brain cancer	9.42e-05	0.0306	CbGpPWpGaD
Idarubicin—Rash—Procarbazine—brain cancer	9.41e-05	0.00144	CcSEcCtD
Idarubicin—Dermatitis—Procarbazine—brain cancer	9.4e-05	0.00144	CcSEcCtD
Idarubicin—Headache—Procarbazine—brain cancer	9.35e-05	0.00143	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	9.35e-05	0.00143	CcSEcCtD
Idarubicin—Infection—Carmustine—brain cancer	9.28e-05	0.00142	CcSEcCtD
Idarubicin—Angiopathy—Etoposide—brain cancer	9.22e-05	0.00141	CcSEcCtD
Idarubicin—Immune system disorder—Etoposide—brain cancer	9.18e-05	0.0014	CcSEcCtD
Idarubicin—Thrombocytopenia—Carmustine—brain cancer	9.14e-05	0.0014	CcSEcCtD
Idarubicin—Body temperature increased—Hydroxyurea—brain cancer	9.13e-05	0.0014	CcSEcCtD
Idarubicin—Chills—Etoposide—brain cancer	9.12e-05	0.00139	CcSEcCtD
Idarubicin—Anaphylactic shock—Temozolomide—brain cancer	9.02e-05	0.00138	CcSEcCtD
Idarubicin—Alopecia—Etoposide—brain cancer	8.98e-05	0.00137	CcSEcCtD
Idarubicin—Infection—Temozolomide—brain cancer	8.97e-05	0.00137	CcSEcCtD
Idarubicin—Anorexia—Carmustine—brain cancer	8.9e-05	0.00136	CcSEcCtD
Idarubicin—Nausea—Procarbazine—brain cancer	8.87e-05	0.00136	CcSEcCtD
Idarubicin—Thrombocytopenia—Temozolomide—brain cancer	8.84e-05	0.00135	CcSEcCtD
Idarubicin—Skin disorder—Temozolomide—brain cancer	8.77e-05	0.00134	CcSEcCtD
Idarubicin—Anorexia—Temozolomide—brain cancer	8.6e-05	0.00132	CcSEcCtD
Idarubicin—Hypersensitivity—Hydroxyurea—brain cancer	8.51e-05	0.0013	CcSEcCtD
Idarubicin—ABCC1—Irinotecan Pathway—APC—brain cancer	8.43e-05	0.0274	CbGpPWpGaD
Idarubicin—Anaemia—Etoposide—brain cancer	8.18e-05	0.00125	CcSEcCtD
Idarubicin—Decreased appetite—Carmustine—brain cancer	8.12e-05	0.00124	CcSEcCtD
Idarubicin—Leukopenia—Etoposide—brain cancer	7.92e-05	0.00121	CcSEcCtD
Idarubicin—Diarrhoea—Hydroxyurea—brain cancer	7.9e-05	0.00121	CcSEcCtD
Idarubicin—Decreased appetite—Temozolomide—brain cancer	7.85e-05	0.0012	CcSEcCtD
Idarubicin—Convulsion—Etoposide—brain cancer	7.67e-05	0.00117	CcSEcCtD
Idarubicin—Gastrointestinal pain—Carmustine—brain cancer	7.64e-05	0.00117	CcSEcCtD
Idarubicin—Chest pain—Etoposide—brain cancer	7.53e-05	0.00115	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	7.48e-05	0.00114	CcSEcCtD
Idarubicin—Body temperature increased—Carmustine—brain cancer	7.38e-05	0.00113	CcSEcCtD
Idarubicin—Abdominal pain—Carmustine—brain cancer	7.38e-05	0.00113	CcSEcCtD
Idarubicin—Gastrointestinal pain—Temozolomide—brain cancer	7.38e-05	0.00113	CcSEcCtD
Idarubicin—Vomiting—Hydroxyurea—brain cancer	7.34e-05	0.00112	CcSEcCtD
Idarubicin—Rash—Hydroxyurea—brain cancer	7.28e-05	0.00111	CcSEcCtD
Idarubicin—Dermatitis—Hydroxyurea—brain cancer	7.28e-05	0.00111	CcSEcCtD
Idarubicin—Headache—Hydroxyurea—brain cancer	7.24e-05	0.00111	CcSEcCtD
Idarubicin—Anaphylactic shock—Etoposide—brain cancer	7.22e-05	0.0011	CcSEcCtD
Idarubicin—Infection—Etoposide—brain cancer	7.17e-05	0.0011	CcSEcCtD
Idarubicin—Urticaria—Temozolomide—brain cancer	7.17e-05	0.0011	CcSEcCtD
Idarubicin—Body temperature increased—Temozolomide—brain cancer	7.13e-05	0.00109	CcSEcCtD
Idarubicin—Abdominal pain—Temozolomide—brain cancer	7.13e-05	0.00109	CcSEcCtD
Idarubicin—Thrombocytopenia—Etoposide—brain cancer	7.07e-05	0.00108	CcSEcCtD
Idarubicin—Skin disorder—Etoposide—brain cancer	7.01e-05	0.00107	CcSEcCtD
Idarubicin—Anorexia—Etoposide—brain cancer	6.88e-05	0.00105	CcSEcCtD
Idarubicin—Hypersensitivity—Carmustine—brain cancer	6.88e-05	0.00105	CcSEcCtD
Idarubicin—Nausea—Hydroxyurea—brain cancer	6.86e-05	0.00105	CcSEcCtD
Idarubicin—TOP2A—Gastric Cancer Network 1—APC—brain cancer	6.8e-05	0.0221	CbGpPWpGaD
Idarubicin—Hypersensitivity—Temozolomide—brain cancer	6.65e-05	0.00102	CcSEcCtD
Idarubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—brain cancer	6.62e-05	0.0215	CbGpPWpGaD
Idarubicin—Diarrhoea—Carmustine—brain cancer	6.39e-05	0.000977	CcSEcCtD
Idarubicin—Decreased appetite—Etoposide—brain cancer	6.28e-05	0.00096	CcSEcCtD
Idarubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—brain cancer	6.26e-05	0.0203	CbGpPWpGaD
Idarubicin—Diarrhoea—Temozolomide—brain cancer	6.17e-05	0.000944	CcSEcCtD
Idarubicin—TOP2A—Circadian rythm related genes—NTRK3—brain cancer	6.12e-05	0.0199	CbGpPWpGaD
Idarubicin—Vomiting—Carmustine—brain cancer	5.94e-05	0.000908	CcSEcCtD
Idarubicin—Gastrointestinal pain—Etoposide—brain cancer	5.91e-05	0.000903	CcSEcCtD
Idarubicin—Rash—Carmustine—brain cancer	5.89e-05	0.000901	CcSEcCtD
Idarubicin—Dermatitis—Carmustine—brain cancer	5.88e-05	0.0009	CcSEcCtD
Idarubicin—Headache—Carmustine—brain cancer	5.85e-05	0.000895	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	5.84e-05	0.019	CbGpPWpGaD
Idarubicin—Vomiting—Temozolomide—brain cancer	5.74e-05	0.000878	CcSEcCtD
Idarubicin—Urticaria—Etoposide—brain cancer	5.74e-05	0.000877	CcSEcCtD
Idarubicin—Abdominal pain—Etoposide—brain cancer	5.71e-05	0.000873	CcSEcCtD
Idarubicin—Body temperature increased—Etoposide—brain cancer	5.71e-05	0.000873	CcSEcCtD
Idarubicin—Rash—Temozolomide—brain cancer	5.69e-05	0.00087	CcSEcCtD
Idarubicin—Dermatitis—Temozolomide—brain cancer	5.68e-05	0.000869	CcSEcCtD
Idarubicin—Headache—Temozolomide—brain cancer	5.65e-05	0.000865	CcSEcCtD
Idarubicin—Nausea—Carmustine—brain cancer	5.55e-05	0.000848	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	5.49e-05	0.0178	CbGpPWpGaD
Idarubicin—Nausea—Temozolomide—brain cancer	5.36e-05	0.00082	CcSEcCtD
Idarubicin—Hypersensitivity—Etoposide—brain cancer	5.32e-05	0.000814	CcSEcCtD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	5.2e-05	0.0169	CbGpPWpGaD
Idarubicin—Diarrhoea—Etoposide—brain cancer	4.94e-05	0.000756	CcSEcCtD
Idarubicin—Vomiting—Etoposide—brain cancer	4.59e-05	0.000702	CcSEcCtD
Idarubicin—Rash—Etoposide—brain cancer	4.55e-05	0.000696	CcSEcCtD
Idarubicin—Dermatitis—Etoposide—brain cancer	4.55e-05	0.000696	CcSEcCtD
Idarubicin—Headache—Etoposide—brain cancer	4.52e-05	0.000692	CcSEcCtD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	4.45e-05	0.0145	CbGpPWpGaD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	4.39e-05	0.0143	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—CTNNB1—brain cancer	4.38e-05	0.0142	CbGpPWpGaD
Idarubicin—Nausea—Etoposide—brain cancer	4.29e-05	0.000656	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—SKP2—brain cancer	4.11e-05	0.0133	CbGpPWpGaD
Idarubicin—ABCC1—S1P1 pathway—VEGFA—brain cancer	3.95e-05	0.0128	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	3.92e-05	0.0127	CbGpPWpGaD
Idarubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—brain cancer	3.75e-05	0.0122	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDK6—brain cancer	3.66e-05	0.0119	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	3.61e-05	0.0117	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—MYC—brain cancer	3.55e-05	0.0115	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	3.47e-05	0.0113	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—EGFR—brain cancer	3.47e-05	0.0113	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—PPP1R12A—brain cancer	3.32e-05	0.0108	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	3.28e-05	0.0107	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	3.11e-05	0.0101	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	3e-05	0.00975	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—PPP1R12A—brain cancer	2.97e-05	0.00964	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—TP53—brain cancer	2.91e-05	0.00947	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CCNE1—brain cancer	2.76e-05	0.00896	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	2.63e-05	0.00853	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—PCNA—brain cancer	2.44e-05	0.00794	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.16e-05	0.00701	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.12e-05	0.00687	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDK4—brain cancer	2.11e-05	0.00686	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.09e-05	0.00679	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—SIRT1—brain cancer	2.03e-05	0.0066	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	1.94e-05	0.00631	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	1.94e-05	0.0063	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP2C9—brain cancer	1.92e-05	0.00623	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	1.89e-05	0.00614	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	1.88e-05	0.00612	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	1.85e-05	0.00601	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	1.64e-05	0.00533	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—brain cancer	1.61e-05	0.00524	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.6e-05	0.0052	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—brain cancer	1.55e-05	0.00505	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—CDK4—brain cancer	1.54e-05	0.00499	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—SKP2—brain cancer	1.51e-05	0.00489	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.51e-05	0.00489	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—brain cancer	1.36e-05	0.00443	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—SKP2—brain cancer	1.35e-05	0.00438	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDK6—brain cancer	1.34e-05	0.00436	CbGpPWpGaD
Idarubicin—ABCC1—Disease—DTX2—brain cancer	1.29e-05	0.0042	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—brain cancer	1.28e-05	0.00415	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDK6—brain cancer	1.2e-05	0.0039	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.2e-05	0.0039	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.17e-05	0.0038	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—MYC—brain cancer	1.09e-05	0.00355	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.03e-05	0.00336	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.02e-05	0.00332	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCNE1—brain cancer	1.01e-05	0.00329	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HES5—brain cancer	9.49e-06	0.00308	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—BRCA2—brain cancer	9.34e-06	0.00303	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCNE1—brain cancer	9.04e-06	0.00294	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.01e-06	0.00293	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—PCNA—brain cancer	8.96e-06	0.00291	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	8.7e-06	0.00283	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.29e-06	0.00269	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.11e-06	0.00263	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—PCNA—brain cancer	8.01e-06	0.0026	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDK4—brain cancer	7.75e-06	0.00252	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP2C9—brain cancer	7.31e-06	0.00238	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDK4—brain cancer	6.93e-06	0.00225	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.81e-06	0.00221	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—TP53—brain cancer	6.53e-06	0.00212	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IDH1—brain cancer	6.38e-06	0.00207	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—BSG—brain cancer	6.22e-06	0.00202	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HEY1—brain cancer	6.05e-06	0.00197	CbGpPWpGaD
Idarubicin—ABCC1—Disease—DLL1—brain cancer	5.93e-06	0.00193	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—brain cancer	5.92e-06	0.00192	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—IDH1—brain cancer	5.35e-06	0.00174	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.34e-06	0.00173	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CDKN2A—brain cancer	5.29e-06	0.00172	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ENO2—brain cancer	5.05e-06	0.00164	CbGpPWpGaD
Idarubicin—ABCC1—Disease—SHH—brain cancer	5.05e-06	0.00164	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCND1—brain cancer	5e-06	0.00162	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCND1—brain cancer	4.47e-06	0.00145	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.35e-06	0.00141	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—ENO2—brain cancer	4.23e-06	0.00137	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MYC—brain cancer	4.01e-06	0.0013	CbGpPWpGaD
Idarubicin—ABCC1—Disease—VAV1—brain cancer	3.65e-06	0.00118	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MYC—brain cancer	3.59e-06	0.00117	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP2C9—brain cancer	3.28e-06	0.00106	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HES1—brain cancer	3.14e-06	0.00102	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PDGFRA—brain cancer	2.99e-06	0.00097	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—brain cancer	2.95e-06	0.000957	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—BSG—brain cancer	2.79e-06	0.000905	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—BSG—brain cancer	2.76e-06	0.000898	CbGpPWpGaD
Idarubicin—ABCC1—Disease—IRS2—brain cancer	2.62e-06	0.000851	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—IDH1—brain cancer	2.4e-06	0.000779	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—IDH1—brain cancer	2.38e-06	0.000772	CbGpPWpGaD
Idarubicin—ABCC1—Disease—APC—brain cancer	2.31e-06	0.000752	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CG—brain cancer	1.94e-06	0.00063	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.93e-06	0.000628	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—ENO2—brain cancer	1.89e-06	0.000615	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—ENO2—brain cancer	1.88e-06	0.00061	CbGpPWpGaD
Idarubicin—ABCC1—Disease—ERBB2—brain cancer	1.8e-06	0.000584	CbGpPWpGaD
Idarubicin—ABCC1—Disease—CTNNB1—brain cancer	1.57e-06	0.000511	CbGpPWpGaD
Idarubicin—ABCC1—Disease—STAT3—brain cancer	1.37e-06	0.000445	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MYC—brain cancer	1.27e-06	0.000414	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGFR—brain cancer	1.25e-06	0.000405	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CG—brain cancer	8.69e-07	0.000282	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CG—brain cancer	8.62e-07	0.00028	CbGpPWpGaD
